Home» Circulars» Viewcirculars Back
Supply Offer for Remdessa (remdesivir) by JV Jurabek Laboratories, Uzbekistan


PXL/HO/BEC-005/2021-22                                                                                 Dt: 26.04.2021



Dear Sir/Madam,

Subject: Supply Offer for Remdessa (remdesivir) by JV Jurabek Laboratories, Uzbekistan

We are glad to inform our member companies that Pharmexcil is in receipt of Communication from Embassy of Uzbekistan in New Delhi wherein a leading Pharmaceutical company from Uzbekistan “JV Jurabek Laboratories” has offered to supply Remdessa (remdesivir), a lyophilisate for the preparation of an infusion solution to India.

M/s.JV Jurabek Laboratories is a leading Pharmaceutical Company in Uzbekistan producing infusion, injection, tablets, capsule, antibiotics, and lyophilized products and has registration of products in countries such as Georgia, Azerbaijan, Kirgiz Republic, Tajikistan, Afghanistan, Moldova and others.

Considering the prevailing shortage of the drug in India, interested member companies may like to review and consider the offer by JV Jurabek LaboratoriesThe details of available stock and expected price as intimated are as below for your ready reference: Please find attached the offer received from JV Jurabek Laboratories

Available stock                 :               170 000 vials No1 box

Price CIP INDIA                :               30 USD per box Delivery

Terms                                  :               DHL or by air


Interested member companies are requested to approach the Nodal person of the M/s.JV Jurabek Laboratories directly with a copy to Uzbekistan embassy in New Delhi: i.salimov@mfa.uz.


 Nodal person of JV Jurabek Laboratories

Karieva M.D,General Director

email id: info@jurabek.uz


Local Representative in India: 

Dr. Basava Bhaaskara

Roerich Healthcare Pvt Ltd,

email id: bhaaskara@roerich.in or bhaaskara@gmail.com

Ph.NO: +91 8008002997


With regards


Uday Bhaskar

Director General


Important Note: Members may please note that the above information is circulated on the basis of information received from Embassy of Uzbekistan, New Delhi. Members are advised to make their own decisions before finalizing their business transactions.